Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRV027 for Coagulopathy in COVID-19
NCT04419610Phase 1Completed
- Sponsor
- Imperial College London
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing TRV027 with Placebo (2 arms). Primary endpoint: Coagulopathy Associated With COVID-19 at Day 3. Started Oct 2020; status: completed.
02
Drugs
TRV120027
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04419610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04419610.